Next Article in Journal
Late Clinical Outcomes of Total Arterial Revascularization or Multiple Arterial Grafting Compared to Conventional Single Arterial with Saphenous Vein Grafting for Coronary Surgery
Previous Article in Journal
Median Nerve Stimulation for Treatment of Tics: Randomized, Controlled, Crossover Trial
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JCM
Volume 12
Issue 7
10.3390/jcm12072515
jcm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Potential Relationships between the Median Nerve Cross-Sectional Area and Physical Characteristics in Unilateral Symptomatic Carpal Tunnel Syndrome Patients

by
Akira Ikumi
1,
Yuichi Yoshii
2,*,
Takamasa Kudo
3,
Sho Kohyama
3,
Takeshi Ogawa
4,
Yuki Hara
5 and
Tomoo Ishii
2
1
Department of Orthopaedic Surgery, Tsukuba University Hospital, Tsukuba 305-8576, Japan
2
Department of Orthopaedic Surgery, Tokyo Medical University Ibaraki Medical Center, Ami 300-0395, Japan
3
Department of Orthopaedic Surgery, Kikkoman General Hospital, Noda 278-0005, Japan
4
Department of Orthopaedic Surgery, Mito Medical Center Hospital, Ibaraki 311-3193, Japan
5
Department of Orthopaedic Surgery, National Center of Neurology and Psychiatry, Kodaira 187-8551, Japan
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2023, 12(7), 2515; https://doi.org/10.3390/jcm12072515
Submission received: 10 February 2023 / Revised: 25 March 2023 / Accepted: 26 March 2023 / Published: 27 March 2023
(This article belongs to the Section Orthopedics)
Browse Figures
Versions Notes

Abstract

:
Background: The present study investigated the relationships between the median nerve cross-sectional area (CSA) and physical characteristics in patients with unilateral symptomatic carpal tunnel syndrome (CTS). Methods: Height, weight, body mass index (BMI), disease duration, results of electrodiagnostic testing (EDX), and median nerve CSA at the level of the wrist crease were recorded in 81 patients with CTS who presented with symptoms on only one side. Correlation coefficients between median nerve CSA and physical characteristics, disease duration, and results of EDX were analyzed. Results: Median nerve CSA at the wrist crease (mm2) was significantly larger on the symptomatic side (14.1 ± 3.8) than on the asymptomatic side (11.5 ± 2.9). Median nerve CSA correlated with body weight (correlation coefficient = 0.39) and BMI (correlation coefficient = 0.44) on the asymptomatic side, but not on the symptomatic side. These correlations were slightly stronger in females (correlation coefficient = 0.46) than in males (correlation coefficient = 0.40). No correlations between median nerve CSA and disease duration and the results of EDX were observed in both sides. Conclusions: In patients with unilateral symptomatic CTS, median nerve CSA correlated with BMI only on the asymptomatic side. The present results suggest that the relationship between median nerve CSA and BMI in CTS is significant until symptom onset but may be masked by edema and pseudoneuroma after its onset. A higher BMI is associated with a larger CSA of the median nerve, which may be a risk factor for the development of CTS.

1. Introduction

Carpal tunnel syndrome (CTS) is caused by compression of the median nerve within the carpal tunnel (CT) and is the most common entrapment neuropathy [1]. The general incidence of CTS is estimated to be 0.2–4% [1,2,3,4]. Clinical symptoms, a physical examination, electrodiagnostic testing (EDX), and ultrasonography (US) are commonly combined to diagnose CTS because of the lack of a consensus on a single diagnostic modality [5]. US was previously reported to be as accurate as other reference standards, such as the 6-item CTS symptoms scale (CTS-6) and EDX, with 91% sensitivity and 94% specificity [6,7,8,9]. The median nerve cross-sectional area (CSA) at the CT is the most commonly used ultrasonographic parameter for the diagnosis and severity evaluation of CTS [10,11,12]. In CTS, nerve compression results in a localized circulatory disturbance with the collapse of the blood–nerve barrier increasing endoneurial fluid pressure, with resultant nerve swelling and further impairments in local blood flow [13].
CTS has a bimodal distribution and is more common in women than in men, with onsets after the ages of 40 and 70 years, respectively [14]. Although most cases of CTS are idiopathic, it sometimes occurs secondary to a lesion in the CT, such as a ganglion, tenosynovitis due to rheumatoid arthritis, dialysis amyloidosis, or pyogenic tendonitis. Several risk factors of CTS such as diabetes mellitus, menopause, hypothyroidism, obesity, arthritis, and pregnancy had been mentioned in previous research. Shiri et al. described the relationships between hypothyroidism and CTS [15]. Padua et al. clearly does support the relevance of pregnancy as a risk factor [16]. Pourmemari et al. suggested that both Type 1 and Type 2 diabetes mellitus are risk factors for CTS [17]. Shiri et al. calculated that being overweight increased the risk of carpal tunnel decompression by a factor of 1.5 [18]. Although various risk factors of CTS have been examined in the past, the factors contributing to symptom onset in CTS remain unclear.
CT release is usually effective for CTS patient whose symptoms do not improve with conservative therapy, but symptoms are not relieved to a satisfactory level in about 25% of cases [19]. The recurrence rate after CT release is also reported in 57% about 2 years later [20]. To explain the surgical failure, several pathogeneses of CTS have been proposed in the past. Festen-Schrier and Amadio described the changes in subsynovial connective tissue (SSCT) [21]. Vilensky et al. described the changes in vascular morphology [22]. Sunderland described the increasing intra-computed tomography pressure [23]. Jinrok et al. described the changes in the nerves serving the epineurium and the median nerve itself (neuropathy) [24]. Stecco et al. described that unbalanced tension of epimysial fasciae can affect the paraneural sheath, limiting nerve displacement, and consequently this must be included in carpal tunnel syndrome pathogenesis [25]. The question of whether there is a relationship between physical characteristics and median nerve size in considering mechanical factors such as SSCT remains unclear.
We previously examined the clinical relevance of US and EDX findings of the median nerve in unilateral symptomatic CTS patients. Median nerve CSA at the wrist crease level on US was significantly larger on the symptomatic side; the area under the curve value was 0.74, and the cut-off value was 11.9 mm2 [26]. Few studies have compared the asymptomatic and symptomatic sides in the same CTS patients. We hypothesized that physical characteristics, such as body mass index (BMI), contribute to the development of CTS symptoms. Therefore, the present study investigated the relationships between median nerve CSA on US and physical characteristics in unilateral symptomatic CTS patients and the incidence of risk factors for CTS.

2. Materials and Methods

The protocol for the present study was reviewed and approved by our Institutional Review Board (approval number T2020-0061). Informed consent was obtained from all patients for inclusion in the present study.
The bilateral wrist joints of 81 unilateral symptomatic idiopathic CTS patients (162 wrists, 26 males, 55 females, 30–89 years, mean 65.9 years) were evaluated. Patients suspected of having secondary CTS due to chronic kidney disease, thyroid disease, diabetes mellitus, and rheumatoid arthritis were excluded from the analysis. Patients with a history of upper limb surgery were also excluded.
CTS was diagnosed based on clinical symptoms and the findings of EDX and US as previously described [26,27]. We defined unilateral symptomatic CTS as patients with characteristic symptoms on one side of the hand and no symptoms on the other side. A single experienced hand surgeon (YY) discriminated between the asymptomatic and symptomatic sides based on an interview and clinical findings. Each patient’s physical characteristics, namely, height, body weight, and BMI, disease duration, and the results of EDX (the latencies of the compound muscle action potential (CMAP) and the sensory nerve action potential (SNAP) were retrospectively recorded from medical records.
The EDX was performed using a standard electromyography system (Neuropack MEB-2208, Nihon Kohden Co., Tokyo, Japan). All studies were performed by a clinical technician who was blinded to clinical symptoms. At the time of the EDX, room temperature was maintained at 27 °C. Among patients with cold hands, the hands were warmed to bring the skin temperature closer to room temperature. In the motor conduction study, the CMAP of the abductor pollicis brevis muscle was recorded. CMAP was induced by a stimulation 7-cm proximal to the recording electrode. In the sensory conduction study, a stimulating electrode was placed at the index finger, and a recording electrode was placed 14-cm proximal to the stimulating electrode. The SNAP was recorded. The latencies of CMAP and SNAP were measured. The result of distal latency of CMAP (ms) was divided into six categories, and the correlation was analyzed using Spearman’s rank correlation coefficient as follows: under 4.0 = 1, 4.1 to 6.0 = 2, 6.1 to 8.0 = 3, 8.1 to 10.0 = 4, over 10.1 = 5, unmeasurable = 6. The result of sensory nerve conduction velocity (m/s) was divided into four categories and the correlation was analyzed using Spearman’s rank correlation coefficient as follows: over 40 = 1, 20 to 39.9 = 2, 0 to 19.9 = 3, unmeasurable = 4.
Median nerve CSA was measured using the following method: US was routinely performed on patients with suspected CTS to differentiate abnormalities around the CT. During the diagnostic process, median nerve CSA was measured at the wrist crease level (Figure 1). Each patient was asked to sit and place their forearm on the table with the palmar side up. An ultrasound scanner (Hi Vision Avius; Hitachi Aloka Medical, Ltd., Tokyo, Japan) equipped with a linear array transducer was set to a depth of 20 mm. The frequency of the transducer was 15 MHz. Cross-sectional ultrasonographic images of the CS were analyzed using ImageJ Software (National Institutes of Health, Bethesda, MD, USA). The median nerve was outlined, and its area was calculated. US was performed by a single hand surgeon (YY) who is certified as a specialist and instructor by the Japanese Society of Surgery of the Hand.
Statistical analyses were performed using the methods described herein. Results are expressed as the mean ± standard deviation. Differences between the symptomatic and asymptomatic sides and between the sexes were evaluated with Welch’s t-test. Values of p < 0.05 were considered to be significant. Pearson’s product–ratio correlation analysis was used to measure correlation coefficients between median nerve CSA and height, weight, BMI, and disease duration on the symptomatic and asymptomatic sides. Spearman’s rank correlation coefficient was used to measure correlation coefficients between median nerve CSA and the results of NCS on the symptomatic and asymptomatic sides. According to Cohen’s recommendation, an absolute value of correlation coefficient of 0.1 is classified as small, an absolute value of 0.3 is classified as medium, and one of 0.5 is classified as large [28]. All analyses were performed using Bellcurve for Excel (version 2.14) and IBM SPSS statistics (version 28.0.1.1).

3. Results

Table 1 shows patient demographics. Height and body weight were significantly larger in males than in females (p < 0.01). No significant differences were observed in age or BMI by sex (p = 0.43 in age, and p = 0.75 in BMI).
The average disease duration was 17.0 ± 27.9 (range 1 to 120) months.
Table 2 shows the results of EDX categorization. There were significant differences between the symptomatic and asymptomatic side (p < 0.01). Both distal latency and sensory nerve conduction velocity were significantly worth in symptomatic side.
The median nerve CSA of the asymptomatic/symptomatic sides (mm2) were 11.2 ± 2.6/14.0 ± 4.4 in males, 11.6 ± 3.0/14.1 ± 3.6 in females, and 11.5 ± 2.9/14.1 ± 3.8 in total. Median nerve CSA was significantly larger on the symptomatic side than on the asymptomatic side in all comparisons (male, female, and total, p < 0.01) (Figure 2). No significant differences were noted between the sexes (p = 0.58 on the asymptomatic side, and p = 0.93 on the symptomatic side).
The relationships between height and CSA are shown in Figure 3. Correlation coefficients were 0.10 on the asymptomatic side and 0.09 on the symptomatic side. Height did not correlate with CSA on either side.
The relationships between body weight and CSA are shown in Figure 4. Correlation coefficients were 0.39 on the asymptomatic side and 0.18 on the symptomatic side. Weight medium correlated with CSA on the asymptomatic side only (p < 0.05).
The relationships between BMI and CSA are shown in Figure 5. Correlation coefficients were 0.44 on the asymptomatic side and 0.18 on the symptomatic side. On the asymptomatic side, correlation coefficients between BMI and CSA by sex were 0.40 in males and 0.46 in females. BMI medium correlated with CSA on the asymptomatic side in both sexes (p < 0.05); slightly stronger in females than in males.
Correlation coefficients between median nerve CSA and disease duration were −0.14 on the asymptomatic side and −0.08 on the symptomatic side. There was no correlation between median nerve CSA and disease duration on both sides (p = 0.24 on the asymptomatic side and p = 0.51 on the symptomatic side).
Correlation coefficients between median nerve CSA and distal latency of the EDX were 0.13 on the asymptomatic side and 0.08 on the symptomatic side. Correlation coefficients between median nerve CSA and sensory nerve conduction velocity of the EDX were 0.19 on the asymptomatic side and 0.15 on the symptomatic side. No correlations were observed between median nerve CSA and the results of EDX on both side (p > 0.05).

4. Discussion

In the present study, median nerve CSA was significantly larger on the symptomatic side. Furthermore, weight/BMI correlated with median nerve CSA on the asymptomatic side. On the other hand, physical characteristics did not correlate with median nerve CSA on the symptomatic side. No significant differences were observed in CSA between the sexes even though physical characteristics significantly differed.
US on median nerve CSA have been compared between healthy controls and patients with peripheral neuropathy. A systematic review reported a mean normative reference value of 8.74 mm2 for median nerve CSA at the CT entrance, which is approximately the same site as the wrist crease assessed in the present study (n = 1863) [29]. Furthermore, the systematic review found no correlation between age or sex and reported a value for median nerve CSA at the CT inlet that appeared to be similar between each region. On the other hand, individual and site-specific differences in median nerve CSA were not small. Among studies measuring normal median nerve CSA at the CT inlet level, individual values widely ranged between 7 and 10 mm2 (lower and upper bounds of 95% CI, respectively) [29]. Nakamichi et al. measured the median nerve CSA of CTS patients at three different levels (the distal edge of the flexor retinaculum, the hook of the hamate, and at the wrist crease) and suggested that the median nerve had an hourglass-like shape [30]. Since there are large individual differences in normal values and CSA values vary depending on the measurement site, this study was validated by the difference in median nerve CSA between the symptomatic and asymptomatic sides in unilateral symptomatic CTS patients. Although median nerve CSA at the CT inlet significantly differed between the asymptomatic and symptomatic sides in patients with unilateral symptomatic CTS, CSA on the asymptomatic side (11.5 ± 2.9 mm2) was also higher than normal values in previous studies. Different CSA measuring methods in each study may have affected the data obtained; however, CTS often occurs bilaterally, and the asymptomatic side may have also been affected by constriction at the CT. The usefulness of CSA measurements in patients with unilateral symptomatic CTS is that interventions at the time of symptom onset on one side may prevent the development of symptoms on the asymptomatic side. To validate the usefulness of median nerve CSA in unilateral symptomatic CTS patients in the future, it is necessary to define whether the measured median nerve CSA is an enlarged condition for each individual because of individual differences in median nerve CSA. Hobson-Webb et al. proposed a method to quantify local nerve enlargement by comparing the wrist and forearm CSA of the median nerve and reported that the wrist-to-forearm CSA ratio improved the diagnostic accuracy of CTS over a single CSA measurement at the CT inlet [31]. Therefore, additional studies are needed to validate the relationship between median nerve CSA and the development of CTS by using CSA ratios at multiple sites in the same patient and also by using the CSA ratio between the asymptomatic and symptomatic sides.
The cut-off value for median nerve CSA on US to diagnose CTS reportedly varied between 9 and 14 mm2, with sensitivity of 57–94% and specificity of 57–98% [9,32,33,34]. Furthermore, a meta-analysis reported pooled sensitivity and specificity of US for the diagnosis of CTS of 77.6% (95% CI 71.6–83.6%) and 86.8% (95% CI 78.9–94.8%), respectively. Another recent meta-analysis revealed that its diagnostic odds ratio may be as high as 31.11 (95% CI, 20.42–47.40) [35,36]. Although sensitivity and specificity widely varied among these studies, the main difficulty associated with diagnosing CTS by median nerve CSA is that it does not take into account differences in normative nerve sizes due to race, sex, and body characteristics. Although there were significant sex differences in physical characteristics in the present study, median nerve CSA did not significantly differ between males and females on the asymptomatic and symptomatic sides. Furthermore, based on the lack of a correlation between height and CSA, median nerve CSA may not correlate with body size, as represented by height. On the other hand, since the CT area depends on the morphology and size of the carpal bones that comprise the CT, the area ratio of the median nerve to the CT may be larger in females than in males. This may be one reason why CTS occurs more frequently in females.
Regarding the relationships between physical characteristics and median nerve CSA, previous studies suggested a positive correlation between BMI and median nerve CSA [37,38,39,40,41]. Cartwright et al. reported that mean age based on BMI was a major parameter for predicting median nerve CSA in healthy subjects [42]. Other studies demonstrated that BMI and diabetes were associated with larger median nerves at the CT [39,40,41]. An MRI-based median nerve CSA study also showed that CSA increased with BMI in non-CTS patients, and obese patients with CTS had larger CSA values at the CT inlet level [42]. The mechanism by which obesity/high BMI increases median nerve CSA is unknown. High lipid conditions due to obesity may be involved. Intraneural adipose cells are present inside nerves [43]. Reina et al. examined the distribution of intraneural adipose cells in the sciatic nerve using a scanning electron microscope and reported that adipose tissue inside a nerve surrounded the fascicles to form adipose sheaths that separated the fascicles from one another [44]. High BMI due to obesity promotes the proliferation of adipocytes, including intraneural adipose cells. An increase in the median nerve CSA with obesity may result in median nerve constriction and the development of CTS. CTS, which occurs via the same mechanism as the above condition, is also observed in patients with lipofibromatous hamartoma (LFH) of the median nerve. LFH is a condition in which fat is deposited in the nerves, and the pathogenesis of this disease is considered to be congenital and slowly progressive [45]. Although previous studies reported that higher BMI and obesity were associated with a higher incidence of CTS [46,47,48], BMI/weight did not correlate with median nerve CSA on the symptomatic side. The prolonged constriction of peripheral nerves results in the formation of a pseudoneuroma (enlargement of median nerve CSA) proximal to the constriction site. The formation of a pseudoneuroma may mask the relationship between median nerve CSA on the symptomatic side and BMI. To verify this hypothesis, median nerve CSA changes on the asymptomatic side need to be tracked in future studies.
There are several limitations that need to be addressed. First, our measurements were only taken at the proximal CT level. To verify the correlations between median nerve CSA and physical characteristics on the symptomatic side, CSA may need to be measured at multiple sites, such as the CT outlet or forearm. Second, the sample size of this study was insufficient in the extent to which physical characteristics affect median nerve CSA compared with other variables which might have an impact on the CSA measurements such as patient age or any independent measure of the severity or duration of CTS. To verify whether physical characteristics truly affect median nerve CSA, additional study by accumulating cases to conduct multivariate analysis is necessary in the future. Thirdly, since many patients with CTS exhibit symptoms in both wrists, the unaffected side in the present study may develop CTS in the future. However, the strength of the present study is that we compared pre-onset and post-onset conditions. Another limitation is that patient backgrounds between sexes were not unified by numbers or physical characteristics. More accurate validation is needed to accumulate more cases in the future. Finally, there is the potential risk of a measurement bias because the CSA measurement by US was performed by one evaluator. Although the diagnosis was confirmed by an electrophysiological test, blind ultrasonography may need to be considered in future studies.

5. Conclusions

BMI/weight medium correlated with median nerve CSA on the asymptomatic side in unilateral symptomatic idiopathic CTS patients. The present results suggest that the relationship between median nerve CSA and BMI in CTS is significant until symptom onset but may be masked by edema and pseudoneuroma after its onset. A higher BMI is associated with a greater CSA of the median nerve, which may be a risk factor for the development of CTS.

Author Contributions

Conceptualization, Y.Y.; methodology, Y.Y.; software, Y.Y.; validation, A.I. and Y.Y.; formal analysis, Y.Y.; investigation, Y.Y. and T.K.; resources, Y.Y.; data curation, Y.Y. and T.K.; writing—original draft preparation, A.I.; writing—review and editing, Y.Y.; visualization, A.I.; supervision, S.K., T.O., Y.H. and T.I.; project administration, Y.Y.; funding acquisition, Y.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The present study was conducted in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of Tokyo Medical University (T2020-0061, 10 June 2020).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patient(s) to publish this paper.

Data Availability Statement

The datasets analyzed during the present study are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. de Krom, M.C.; Knipschild, P.G.; Kester, A.D.; Thijs, C.T.; Boekkooi, P.F.; Spaans, F. Carpal tunnel syndrome: Prevalence in the general population. J. Clin. Epidemiol. 1992, 45, 373–376. [Google Scholar] [CrossRef] [PubMed]
  2. Atroshi, I.; Gummesson, C.; Johnsson, R.; Ornstein, E.; Ranstam, J.; Rosén, I. Prevalence of carpal tunnel syndrome in a general population. JAMA 1999, 282, 153–158. [Google Scholar] [CrossRef]
  3. Bland, J.D.P.; Rudolfer, S.M. Clinical surveillance of carpal tunnel syndrome in two areas of the United Kingdom, 1991–2001. J. Neurol. Neurosurg. Psychiatry 2003, 74, 1674. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Ibrahim, I.; Khan, W.S.; Goddard, N.; Smitham, P. Carpal tunnel syndrome: A review of the recent literature. Open Orthop. J. 2012, 6, 69–76. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. MacDermid, J.C.; Wessel, J. Clinical diagnosis of carpal tunnel syndrome: A systematic review. J. Hand Ther. 2004, 17, 309–319. [Google Scholar] [CrossRef] [Green Version]
  6. Graham, B. The value added by electrodiagnostic testing in the diagnosis of carpal tunnel syndrome. J. Bone Jt. Surg. Am. 2008, 90, 2587–2593. [Google Scholar] [CrossRef]
  7. Fowler, J.R.; Cipolli, W.; Hanson, T. A Comparison of Three Diagnostic Tests for Carpal Tunnel Syndrome Using Latent Class Analysis. J. Bone Jt. Surg. Am. 2015, 97, 1958–1961. [Google Scholar] [CrossRef]
  8. Lee, D.; van Holsbeeck, M.T.; Janevski, P.K.; Ganos, D.L.; Ditmars, D.M.; Darian, V.B. Diagnosis of carpal tunnel syndrome. Ultrasound versus electromyography. Radiol. Clin. N. Am. 1999, 37, 859–872. [Google Scholar] [CrossRef]
  9. Wong, S.M.; Griffith, J.F.; Hui, A.C.; Lo, S.K.; Fu, M.; Wong, K.S. Carpal tunnel syndrome: Diagnostic usefulness of sonography. Radiology 2004, 232, 93–99. [Google Scholar] [CrossRef]
  10. Pulikkottil, B.J.; Schub, M.; Kadow, T.R.; Wang, W.; Fowler, J.R. Correlating Median Nerve Cross-sectional Area With Nerve Conduction Studies. J. Hand Surg. Am. 2016, 41, 958–962. [Google Scholar] [CrossRef]
  11. Wessel, L.E.; Marshall, D.C.; Stepan, J.G.; Sacks, H.A.; Nwawka, O.K.; Miller, T.T.; Fufa, D.T. Sonographic Findings Associated With Carpal Tunnel Syndrome. J. Hand Surg. Am. 2019, 44, 374–381. [Google Scholar] [CrossRef]
  12. Yoshii, Y.; Zhao, C.; Amadio, P.C. Recent advances in ultrasound diagnosis of carpal tunnel syndrome. Diagnostics 2020, 10, 596. [Google Scholar] [CrossRef] [PubMed]
  13. Sugimoto, H.; Miyaji, N.; Ohsawa, T. Carpal tunnel syndrome: Evaluation of median nerve circulation with dynamic contrast-enhanced MR imaging. Radiology 1994, 190, 459–466. [Google Scholar] [CrossRef] [PubMed]
  14. Stevens, J.C. AAEM minimonograph #26: The electrodiagnosis of carpal tunnel syndrome. American Association of Electrodiagnostic Medicine. Muscle Nerve 1997, 20, 1477–1486. [Google Scholar] [PubMed]
  15. Shiri, R. Hypothyroidism and carpal tunnel syndrome: A meta-analysis. Muscle Nerve 2014, 50, 879–883. [Google Scholar] [CrossRef] [PubMed]
  16. Padua, L.; Di Pasquale, A.; Pazzaglia, C.; Liotta, G.A.; Librante, A.; Mondelli, M. Systematic review of pregnancy-related carpal tunnel syndrome. Muscle Nerve 2010, 42, 697–702. [Google Scholar] [CrossRef] [PubMed]
  17. Pourmemari, M.H.; Shiri, R. Diabetes as a risk factor for carpal tunnel syndrome: A systematic review and meta-analysis. Diabet. Med. 2016, 33, 10–16. [Google Scholar] [CrossRef]
  18. Shiri, R.; Pourmemari, M.H.; Falah-Hassani, K.; Viikari-Juntura, E. The effect of excess body mass on the risk of carpal tunnel syndrome: A meta-analysis of 58 studies. Obes. Rev. 2015, 16, 1094–1104. [Google Scholar] [CrossRef]
  19. Bland, J.D. Treatment of carpal tunnel syndrome. Muscle Nerve 2007, 36, 167–171. [Google Scholar] [CrossRef]
  20. Nancollas, M.P.; Peimer, C.A.; Wheeler, D.R.; Sherwin, F.S. Long-term results of carpal tunnel release. J. Hand Surg. Br. 1995, 20, 470–474. [Google Scholar] [CrossRef]
  21. Festen-Schrier, V.; Amadio, P.C. The biomechanics of subsynovial connective tissue in health and its role in carpal tunnel syndrome. J. Electromyogr. Kinesiol. 2018, 38, 232–239. [Google Scholar] [CrossRef]
  22. Vilensky, J.A.; Gilman, S.; Casey, K. Sir Victor Horsley, Mr John Marshall, the nervi nervorum, and pain: More than a century ahead of their time. Arch. Neurol. 2005, 62, 499–501. [Google Scholar] [CrossRef] [PubMed]
  23. Sunderland, S. The nerve lesion in the carpal tunnel syndrome. J. Neurol. Neurosurg. Psychiatry 1976, 39, 615–626. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Jinrok, O.; Zhao, C.; Amadio, P.C.; An, K.N.; Zobitz, M.E.; Wold, L.E. Vascular pathologic changes in the flexor tenosynovium (subsynovial connective tissue) in idiopathic carpal tunnel syndrome. J. Orthop. Res. 2004, 22, 1310–1315. [Google Scholar] [CrossRef]
  25. Stecco, C.; Giordani, F.; Fan, C.; Biz, C.; Pirri, C.; Frigo, A.C.; Fede, C.; Macchi, V.; Masiero, S.; De Caro, R. Role of fasciae around the median nerve in pathogenesis of carpal tunnel syndrome: Microscopic and ultrasound study. J. Anat. 2020, 236, 660–667. [Google Scholar] [CrossRef]
  26. Kudo, T.; Yoshii, Y.; Hara, Y.; Ogawa, T.; Ishii, T. Clinical Relevance of Ultrasonographic and Electrophysiological Findings of the Median Nerve in Unilateral Carpal Tunnel Syndrome Patients. Diagnostics 2022, 12, 2799. [Google Scholar] [CrossRef]
  27. Yoshii, Y.; Tanaka, T.; Ishii, T. Correlations of Median Nerve Area, Strain, and Nerve Conduction in Carpal Tunnel Syndrome Patients. Hand 2016, 11, 161–167. [Google Scholar] [CrossRef] [Green Version]
  28. Cohen, J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed.; Routledge: Abingdon, UK, 1988. [Google Scholar]
  29. Ng, A.J.T.; Chandrasekaran, R.; Prakash, A.; Mogali, S.R. A systematic review: Normative reference values of the median nerve cross-sectional area using ultrasonography in healthy individuals. Sci. Rep. 2022, 12, 9217. [Google Scholar] [CrossRef]
  30. Nakamichi, K.; Tachibana, S. Ultrasonographic measurement of median nerve cross-sectional area in idiopathic carpal tunnel syndrome: Diagnostic accuracy. Muscle Nerve 2002, 26, 798–803. [Google Scholar] [CrossRef]
  31. Hobson-Webb, L.D.; Massey, J.M.; Juel, V.C.; Sanders, D.B. The ultrasonographic wrist-to-forearm median nerve area ratio in carpal tunnel syndrome. Clin. Neurophysiol. 2008, 119, 1353–1357. [Google Scholar] [CrossRef] [PubMed]
  32. Yesildag, A.; Kutluhan, S.; Sengul, N.; Koyuncuoglu, H.R.; Oyar, O.; Guler, K.; Gulsoy, U.K. The role of ultrasonographic measurements of the median nerve in the diagnosis of carpal tunnel syndrome. Clin. Radiol. 2004, 59, 910–915. [Google Scholar] [CrossRef]
  33. Sernik, R.A.; Abicalaf, C.A.; Pimentel, B.F.; Braga-Baiak, A.; Braga, L.; Cerri, G.G. Ultrasound features of carpal tunnel syndrome: A prospective case-control study. Skelet. Radiol. 2008, 37, 49–53. [Google Scholar] [CrossRef] [PubMed]
  34. Seror, P. Sonography and electrodiagnosis in carpal tunnel syndrome diagnosis, an analysis of the literature. Eur. J. Radiol. 2008, 67, 146–152. [Google Scholar] [CrossRef] [PubMed]
  35. Fowler, J.R.; Gaughan, J.P.; Ilyas, A.M. The sensitivity and specificity of ultrasound for the diagnosis of carpal tunnel syndrome: A meta-analysis. Clin. Orthop. Relat. Res. 2011, 469, 1089–1094. [Google Scholar] [CrossRef] [Green Version]
  36. Torres-Costoso, A.; Martínez-Vizcaíno, V.; Álvarez-Bueno, C.; Ferri-Morales, A.; Cavero-Redondo, I. Accuracy of Ultrasonography for the Diagnosis of Carpal Tunnel Syndrome: A Systematic Review and Meta-Analysis. Arch. Phys. Med. Rehabil. 2018, 99, 758–765.e710. [Google Scholar] [CrossRef]
  37. Kang, K.-H.; Lee, G.-H.; Choi, G.-E.; Hyun, K.-Y. Mean Value of Median Nerve Cross-sectional Area in Healthy 20s and 30s in Busan Area. Biomed. Sci. Lett. 2020, 26, 186–191. [Google Scholar] [CrossRef]
  38. Cartwright, M.S.; Mayans, D.R.; Gillson, N.A.; Griffin, L.P.; Walker, F.O. Nerve cross-sectional area in extremes of age. Muscle Nerve 2013, 47, 890–893. [Google Scholar] [CrossRef] [PubMed]
  39. Tahmaz, M.; Yoon, M.S.; Schellinger, P.D.; Philipps, J. Cross-sectional area in median and ulnar nerve ultrasound correlates with hand volume. Muscle Nerve 2020, 62, 83–88. [Google Scholar] [CrossRef]
  40. Kotb, M.A.; Bedewi, M.A.; Aldossary, N.M.; Mahmoud, G.; Naguib, M.F. Sonographic assessment of carpal tunnel syndrome in diabetic patients with and without polyneuropathy. Medicine 2018, 97, e11104. [Google Scholar] [CrossRef]
  41. Demino, C.; Fowler, J.R. Comparison of Borderline Ultrasound and Nerve Conduction Studies for Carpal Tunnel Syndrome. Hand 2020, 17, 860–864. [Google Scholar] [CrossRef]
  42. Bowers, E.M.R.; Como, C.J.; Dooley, S.W.; Morales-Restrepo, A.; Fowler, J.R. Magnetic Resonance Imaging-Measured Cross-Sectional Area of the Median Nerve. J. Hand Surg. Glob. Online 2022, 4, 93–96. [Google Scholar] [CrossRef] [PubMed]
  43. Kuliasha, C.A.; Spearman, B.S.; Atkinson, E.W.; Furniturewalla, A.; Rustogi, P.; Mobini, S.; Nunamaker, E.B.; Brennan, A.B.; Otto, K.J.; Schmidt, C.E.; et al. Robust and Scalable Tissue-Engineerined Electronic Nerve Interfaces (Teeni). Solid-State Sens. Actuators Microsyst. Work. 2018, 46–49. [Google Scholar]
  44. Reina, M.A.; López, A.; De Andrés, J.A. Adipose tissue within peripheral nerves. Study of the human sciatic nerve. Rev. Esp. Anestesiol. Reanim. 2002, 49, 397–402. [Google Scholar]
  45. Agarwal, S.; Haase, S.C. Lipofibromatous hamartoma of the median nerve. J. Hand Surg. Am. 2013, 38, 392–397; quiz 397. [Google Scholar] [CrossRef] [PubMed]
  46. Lam, N.; Thurston, A. Association of obesity, gender, age and occupation with carpal tunnel syndrome. Aust. N. Z. J. Surg. 1998, 68, 190–193. [Google Scholar] [CrossRef]
  47. Ferry, S.; Hannaford, P.; Warskyj, M.; Lewis, M.; Croft, P. Carpal tunnel syndrome: A nested case-control study of risk factors in women. Am. J. Epidemiol. 2000, 151, 566–574. [Google Scholar] [CrossRef] [Green Version]
  48. Bland, J.D. The relationship of obesity, age, and carpal tunnel syndrome: More complex than was thought? Muscle Nerve 2005, 32, 527–532. [Google Scholar] [CrossRef]
Jcm 12 02515 g001 550
Figure 1. Ultrasound measurement of the median nerve CSA. (A) Unaffected side. (B) Affected side. CSA was measured as the only parameter for the image analysis. Median nerve CSA was measured at the wrist crease level. The median nerve was outlined (white dotted line), and its area was calculated.
Figure 1. Ultrasound measurement of the median nerve CSA. (A) Unaffected side. (B) Affected side. CSA was measured as the only parameter for the image analysis. Median nerve CSA was measured at the wrist crease level. The median nerve was outlined (white dotted line), and its area was calculated.
Jcm 12 02515 g001
Jcm 12 02515 g002 550
Figure 2. Median nerve CSA (mm2). CSA was significantly larger on the symptomatic side in both males and females. * p < 0.05 between the sides.
Figure 2. Median nerve CSA (mm2). CSA was significantly larger on the symptomatic side in both males and females. * p < 0.05 between the sides.
Jcm 12 02515 g002
Jcm 12 02515 g003 550
Figure 3. Relationships between height and CSA. (A) Asymptomatic side. (B) Symptomatic side.
Figure 3. Relationships between height and CSA. (A) Asymptomatic side. (B) Symptomatic side.
Jcm 12 02515 g003
Jcm 12 02515 g004 550
Figure 4. Relationships between weight and CSA. (A) Asymptomatic side. (B) Symptomatic side.
Figure 4. Relationships between weight and CSA. (A) Asymptomatic side. (B) Symptomatic side.
Jcm 12 02515 g004
Jcm 12 02515 g005 550
Figure 5. Relationships between BMI and CSA. (A) Asymptomatic side. (B) Symptomatic side. (C) Male. (D) Female.
Figure 5. Relationships between BMI and CSA. (A) Asymptomatic side. (B) Symptomatic side. (C) Male. (D) Female.
Jcm 12 02515 g005
Table
Table 1. Patient demographics.
Table 1. Patient demographics.
Age (Years Old)Height (cm) *Weight (kg) *BMI
Males67.5 ± 9.4165.9 ± 5.366.9 ± 12.924.2 ± 3.8
Females64.0 ± 12.1153.2 ± 6.558.4 ± 10.324.9 ± 3.9
Total65.3 ± 11.3157.6 ± 8.661.3 ± 11.924.6 ± 3.8
* p < 0.05 between the sexes.
Table
Table 2. The results of EDX.
Table 2. The results of EDX.
CategorySymptomatic SideAsymptomatic Side
Distal latency *1325
22642
3224
470
530
6150
Sensory nerve conduction velocity *11851
22111
310
4271
* p < 0.05 between symptomatic and asymptomatic side.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ikumi, A.; Yoshii, Y.; Kudo, T.; Kohyama, S.; Ogawa, T.; Hara, Y.; Ishii, T. Potential Relationships between the Median Nerve Cross-Sectional Area and Physical Characteristics in Unilateral Symptomatic Carpal Tunnel Syndrome Patients. J. Clin. Med. 2023, 12, 2515. https://doi.org/10.3390/jcm12072515

AMA Style

Ikumi A, Yoshii Y, Kudo T, Kohyama S, Ogawa T, Hara Y, Ishii T. Potential Relationships between the Median Nerve Cross-Sectional Area and Physical Characteristics in Unilateral Symptomatic Carpal Tunnel Syndrome Patients. Journal of Clinical Medicine. 2023; 12(7):2515. https://doi.org/10.3390/jcm12072515

Chicago/Turabian Style

Ikumi, Akira, Yuichi Yoshii, Takamasa Kudo, Sho Kohyama, Takeshi Ogawa, Yuki Hara, and Tomoo Ishii. 2023. "Potential Relationships between the Median Nerve Cross-Sectional Area and Physical Characteristics in Unilateral Symptomatic Carpal Tunnel Syndrome Patients" Journal of Clinical Medicine 12, no. 7: 2515. https://doi.org/10.3390/jcm12072515

APA Style

Ikumi, A., Yoshii, Y., Kudo, T., Kohyama, S., Ogawa, T., Hara, Y., & Ishii, T. (2023). Potential Relationships between the Median Nerve Cross-Sectional Area and Physical Characteristics in Unilateral Symptomatic Carpal Tunnel Syndrome Patients. Journal of Clinical Medicine, 12(7), 2515. https://doi.org/10.3390/jcm12072515

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop